Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 67,732 | 76,544 | 40,608 | 37,460 | 29,963 |
| Cost of Goods | 4,675 | 3,702 | 2,168 | 1,751 | 1,688 |
| Gross Profit | 63,057 | 72,842 | 38,440 | 35,709 | 28,275 |
| Operating Expenses | 37,187 | 37,800 | 31,128 | 29,622 | 28,431 |
| Operating Income | 26,545 | 35,744 | 7,480 | 6,838 | 532 |
| Interest Expense | 5,519 | 626 | 470 | 285 | 40 |
| Other Income | 20 | -5,352 | -3,969 | 27 | 46 |
| Pre-tax Income | 21,046 | 29,766 | 3,041 | 6,580 | 538 |
| Income Tax | 8,300 | 11,827 | -38,760 | 66 | 60 |
| Net Income Continuous | 12,746 | 17,939 | 41,801 | 6,514 | 478 |
| Net Income | $12,746 | $17,939 | $41,801 | $6,514 | $478 |
| EPS Basic Total Ops | 0.88 | 1.24 | 2.96 | 0.44 | 0.04 |
| EPS Basic Continuous Ops | 0.88 | 1.25 | 2.95 | 0.46 | 0.03 |
| EPS Diluted Total Ops | 0.84 | 1.20 | 2.92 | 0.44 | 0.04 |
| EPS Diluted Continuous Ops | 0.84 | 1.20 | 2.91 | 0.45 | 0.03 |
| EBITDA(a) | $29,690 | $38,869 | $10,660 | $8,317 | $1,610 |